DocGo Inc. (NASDAQ:DCGO) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of DocGo Inc. (NASDAQ:DCGO - Get Free Report) have earned an average rating of "Moderate Buy" from the six research firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $4.89.

DCGO has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft cut shares of DocGo from a "buy" rating to a "hold" rating and cut their price target for the company from $5.00 to $2.85 in a research report on Friday. Needham & Company LLC cut their price target on DocGo from $7.00 to $4.00 and set a "buy" rating on the stock in a report on Friday. Finally, Stifel Nicolaus reduced their price objective on shares of DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a research report on Friday.

DocGo Stock Performance

Shares of NASDAQ DCGO traded down $0.03 during midday trading on Friday, reaching $2.96. The stock had a trading volume of 1,875,036 shares, compared to its average volume of 757,345. DocGo has a twelve month low of $2.75 and a twelve month high of $5.68. The company's 50 day moving average price is $4.56 and its 200 day moving average price is $4.02. The firm has a market cap of $302.07 million, a price-to-earnings ratio of 10.57, a price-to-earnings-growth ratio of 14.16 and a beta of 1.00.

Remove Ads

Insider Buying and Selling

In other news, General Counsel Ely D. Tendler sold 23,088 shares of the business's stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the sale, the general counsel now owns 175,645 shares in the company, valued at $779,863.80. The trade was a 11.62 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On DocGo

A number of large investors have recently modified their holdings of DCGO. Invesco Ltd. raised its holdings in DocGo by 1.3% during the fourth quarter. Invesco Ltd. now owns 177,953 shares of the company's stock worth $755,000 after buying an additional 2,312 shares during the last quarter. Summit Investment Advisors Inc. boosted its stake in DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock valued at $45,000 after purchasing an additional 2,968 shares during the last quarter. SG Americas Securities LLC increased its holdings in DocGo by 12.9% during the 4th quarter. SG Americas Securities LLC now owns 43,052 shares of the company's stock worth $183,000 after purchasing an additional 4,905 shares in the last quarter. Rhumbline Advisers raised its stake in shares of DocGo by 4.5% in the fourth quarter. Rhumbline Advisers now owns 142,762 shares of the company's stock worth $605,000 after purchasing an additional 6,204 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in shares of DocGo by 12.3% in the fourth quarter. Victory Capital Management Inc. now owns 57,649 shares of the company's stock valued at $244,000 after purchasing an additional 6,300 shares in the last quarter. 56.44% of the stock is currently owned by institutional investors.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.